Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olodaterol and Ciclesonide FDC vs Free Combination in Healthy Volunteers
NCT02220660Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2009
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, single-blind trial of olodaterol and ciclesonide in asthma (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve at steady state at 14 days and Maximum plasma concentration at 14 days. Started Mar 2009; status: completed.
02
Drugs
olodaterolciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02220660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02220660.